As people lose weight from Ozempic and other diabetes drugs, plastic surgeons see uptick

As we step into a new year, plastic surgery is witnessing groundbreaking advancements and allowing patients to redefine themselves both aesthetically and functionally.

This evolving landscape includes new procedures and pharmaceuticals like semaglutide (Ozempic) and terzepatide (Mounjaro), two drugs that help control blood sugar for people with type 2 diabetes, but also have weight-loss benefits..

The synergy between plastic surgery and pharmaceuticals is particularly evident in cases where patients may benefit from weight management and behavioral modifications. Ozempic and Mounjaro, with their proven track record in promoting weight loss, present an intriguing avenue for collaboration.

Plastic surgery clinics are exploring these drugs to enhance results and improve long-term health for patients. By integrating weight loss with surgical planning, patients can plan both emotionally and economically.

It is imperative that patients choose doctors who will follow them medically as well as surgically so they can complete the process in a safe manner. Very often, a blood test and a good history of the patient are key. These medications are powerful; patients need to be followed by a physician who can monitor them for any detrimental side effects.

In addition to pharmacological treatments, there are other non-invasive treatments that are being used to improve patients’ appearance, both in the face and in the body.

I look forward to answering all your questions relating to plastic surgery and aesthetic treatments. No question is too small or too big for me to answer.

Happy New Year and good health to all.

Dr. Carlos Wolf is a partner in Miami Plastic Surgery and is board certified. Email questions to him at Cwolf@miamiplasticsurgery.com